AA
ALPS Advisors Portfolio holdings
AUM
$17.3B
1-Year Return
13.43%
This Quarter Return
+1.29%
1 Year Return
+13.43%
3 Year Return
+69.62%
5 Year Return
+161.48%
10 Year Return
+94.79%
AUM
$8.89B
AUM Growth
-$1.49B
(-14%)
Cap. Flow
-$1.59B
Cap. Flow
% of AUM
-17.93%
Top 10 Holdings %
Top 10 Hldgs %
47.67%
Holding
1,012
New
106
Increased
478
Reduced
302
Closed
124
Top Buys
| 1 |
Energy Transfer Partners
ET
|
$33.8M |
| 2 |
MMP
Magellan Midstream Partners, L.P.
MMP
|
$30.5M |
| 3 |
Newmont
NEM
|
$30M |
| 4 |
Bristol-Myers Squibb
BMY
|
$29.6M |
| 5 |
Conagra Brands
CAG
|
$24.9M |
Top Sells
| 1 |
Berkshire Hathaway Class A
BRK.A
|
$430M |
| 2 |
JPMorgan Chase
JPM
|
$162M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
$132M |
| 4 |
Pfizer
PFE
|
$111M |
| 5 |
Yum! Brands
YUM
|
$105M |
Sector Composition
| 1 | Energy | 59.33% |
| 2 | Technology | 6.01% |
| 3 | Healthcare | 4.63% |
| 4 | Consumer Discretionary | 3.72% |
| 5 | Financials | 3.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
901
B&G Foods
BGS
$374M
| – | – |
-330,000
| Closed | -$9.86M |
|
902
Blackrock
BLK
$170B
| – | – |
-698
| Closed | -$585K |
|
|
BLUE
903
DELISTED
bluebird bio
BLUE
| – | – |
-6,395
| Closed | -$1.58M |
|
|
904
Berkshire Hathaway Class A
BRK.A
$1.08T
| – | – |
-1,045
| Closed | -$430M |
|
|
BRT
905
BRT Apartments
BRT
$282M
| – | – |
-36,536
| Closed | -$704K |
|
906
Perrigo
PRGO
$3.12B
| – | – |
-5,175
| Closed | -$245K |
|
907
GE Aerospace
GE
$296B
| – | – |
-3,608
| Closed | -$232K |
|
908
Gogo Inc
GOGO
$1.43B
| – | – |
-24,483
| Closed | -$424K |
|
909
Hubbell
HUBB
$23.2B
| – | – |
-1,379
| Closed | -$249K |
|
910
Inovio Pharmaceuticals
INO
$148M
| – | – |
-21,486
| Closed | -$1.85M |
|
911
Disc Medicine
IRON
$2.11B
| – | – |
-1,761
| Closed | -$213K |
|
|
JNPR
912
DELISTED
Juniper Networks
JNPR
| – | – |
-830,422
| Closed | -$22.9M |
|
913
Kellanova
K
$27.8B
| – | – |
-392,315
| Closed | -$23.5M |
|
914
Knowles
KN
$1.85B
| – | – |
-17,653
| Closed | -$331K |
|
915
Kiniksa Pharmaceuticals
KNSA
$2.65B
| – | – |
-83,983
| Closed | -$957K |
|
916
Coca-Cola Femsa
KOF
$17.5B
| – | – |
-9,283
| Closed | -$522K |
|
917
Korro Bio
KRRO
$312M
| – | – |
-844
| Closed | -$298K |
|
918
Kennedy-Wilson Holdings
KW
$1.21B
| – | – |
-13,735
| Closed | -$287K |
|
919
Legend Biotech
LEGN
$6.66B
| – | – |
-177,274
| Closed | -$8.96M |
|
920
Macerich
MAC
$4.74B
| – | – |
-42,475
| Closed | -$710K |
|
921
Madrigal Pharmaceuticals
MDGL
$9.65B
| – | – |
-20,338
| Closed | -$1.62M |
|
922
Medtronic
MDT
$119B
| – | – |
-3,458
| Closed | -$433K |
|
923
MeiraGTx Holdings
MGTX
$619M
| – | – |
-54,308
| Closed | -$716K |
|
924
Mirum Pharmaceuticals
MIRM
$3.82B
| – | – |
-37,401
| Closed | -$745K |
|
925
Marker Therapeutics
MRKR
$11.6M
| – | – |
-10,183
| Closed | -$172K |
|